ER
MRNA icon

Enlightenment Research’s Moderna MRNA Stock Holding History

Enlightenment Research’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,400
Closed -$284K – 51
2022
Q3 		$284K Buy
+2,400
New +$364K 0.63% 59
2021
Q4 		– Sell
-3,795
Closed -$1.46M – 178
2021
Q3 		$1.46M Buy
+3,795
New +$1.4M 1.78% 13
2021
Q1 		– Sell
-23,000
Closed -$2.4M – 173
2020
Q4 		$2.4M Buy
23,000
+16,500
+254% +$1.67M 3.39% 7
2020
Q3 		$460K Buy
+6,500
New +$453K 1.36% 24

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Enlightenment Research's MRNA Position: Q4 2022 in Review

Enlightenment Research sold out of Moderna (MRNA) in Q4 2022, closing a stake of 2,400 shares — an estimated $284K sold.

Enlightenment Research first reported a position in MRNA in Q3 2020 and held it in 4 quarters. The position peaked at $2.4M in Q4 2020. 1,072 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Enlightenment Research reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Enlightenment Research sold 2,400 Moderna shares in Q4 2022, an estimated $284K.
  • Enlightenment Research first reported a position in Moderna in Q3 2020 and held it in 4 quarters.
  • Enlightenment Research's Moderna position peaked at $2.4M in Q4 2020.
  • 1,072 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Enlightenment Research's 13F filing for Q4 2022.